Business Areas

Overview

ㅤㅤNew North River Pharmaceutical was founded in 1990 and was controlled by the listed company Livzon Group in 2002. Since 1997, it has been recognized as a high-tech enterprise for nine consecutive times. With microbial fermentation, semi synthetic technology, and biologics as the core, we focus on the research and development, production, and sales of active pharmaceutical ingredients, pharmaceutical intermediates, and biologics. Our products cover blood glucose lowering, cardiovascular and cerebrovascular diseases, organ transplantation, anti infection, veterinary medicine, etc., and are exported to the global market. We have supply chains from international giants such as Merck and Novartis. It is a leading local pharmaceutical enterprise. It is a relatively large microbial fermentation raw material drug and biopharmaceutical enterprise in Guangdong Province: it has been awarded the titles of 'Green Factory' and 'Intellectual Property Advantage Enterprise' by the country. It has established multiple research and development platforms for the research and application of fermentation and semi synthetic drugs in Guangdong Province, including the Key Laboratory, Enterprise Technology Center, Provincial Fermentation Engineering Technology Center, Provincial Veterinary Drug Engineering Technology Center, Provincial Doctoral Workstation, etc. It has 95 research and development personnel, including 1 doctoral student and 16 master's students. Through four international management system certifications, authorized 56 invention patents, and won the Provincial Science and Technology Achievement Promotion Award, Silver Award in Intellectual Property Innovation and Entrepreneurship Competition, and multiple municipal awards in 2023. In deep cooperation with Zhejiang University, Chinese Academy of Sciences, Sichuan Institute of Anti Japanese Medicine, Tianjin University, Shanghai Jiao Tong University and other universities and colleges, we will focus on the field of high value-added characteristic active pharmaceutical ingredients and biologics in the future.

Core Advantages

Product Series